Description

Gozerelin-Alvogen Implant 3.6 mg Syringe №1

Ingredients:

Gozerelin-Alvogen contains 3.6 mg of the active ingredient goserelin acetate, which is a synthetic hormone that acts as a gonadotropin-releasing hormone (GnRH) agonist.

Dosage:

Gozerelin-Alvogen is administered as a subcutaneous implant with a dosage of 3.6 mg. It is typically given once every 28 days under the supervision of a healthcare provider.

Indications:

Gozerelin-Alvogen is indicated for the treatment of advanced prostate cancer, endometriosis, and certain gynecological disorders. It works by suppressing the production of certain hormones in the body.

Contraindications:

Gozerelin-Alvogen is contraindicated in individuals with a known hypersensitivity to goserelin acetate or any of the other ingredients in the product. It should not be used during pregnancy.

Directions:

Gozerelin-Alvogen should be administered by a healthcare professional. The implant is placed subcutaneously, usually in the abdominal area. It is important to follow the dosing schedule as directed.

Scientific Evidence:

Studies have shown that Gozerelin-Alvogen is effective in the treatment of prostate cancer by reducing testosterone levels, which can slow the growth of cancer cells. Research also supports its use in managing endometriosis symptoms by suppressing estrogen production.

Additional Information:

It is important to discuss any existing medical conditions or medications with your healthcare provider before starting treatment with Gozerelin-Alvogen. Regular monitoring and follow-up visits may be necessary to assess the response to treatment.

Gozerelin-Alvogen works by initially stimulating the release of certain hormones, followed by a sustained suppression of hormone production. This mechanism helps in managing conditions like prostate cancer and endometriosis.

Comparative studies have shown that Gozerelin-Alvogen has similar efficacy to other GnRH agonists in the treatment of prostate cancer, with a favorable side effect profile. Its convenient dosing schedule and long-acting formulation make it a preferred choice for many patients.